Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Autor: Varatharajah, Yogatheesan, Ramanan, Vijay K., Iyer, Ravishankar, Vemuri, Prashanthi, Weiner, Michael W., Aisen, Paul, Petersen, Ronald, Jack, Clifford R., Saykin, Andrew J., Jagust, William, Trojanowki, John Q., Toga, Arthur W., Beckett, Laurel, Green, Robert C., Morris, John, Shaw, Leslie M., Khachaturian, Zaven, Sorensen, Greg, Carrillo, Maria, Kuller, Lew, Raichle, Marc, Paul, Steven, Davies, Peter, Fillit, Howard, Hefti, Franz, Holtzman, David, Mesulam, M. Marcel, Potter, William, Snyder, Peter, Schwartz, Adam, Montine, Tom, Thomas, Ronald G.
Rok vydání: 2019
Předmět:
0301 basic medicine
Oncology
Male
Aging
Complement receptor 1
lcsh:Medicine
Disease
Neurodegenerative
Alzheimer's Disease
0302 clinical medicine
Cognition
Models
80 and over
2.1 Biological and endogenous factors
Alzheimer's Disease including Alzheimer's Disease Related Dementias
Aetiology
lcsh:Science
Cognitive impairment
media_common
Aged
80 and over

screening and diagnosis
Multidisciplinary
biology
Resilience
Psychological

Middle Aged
3. Good health
Other Physical Sciences
Detection
Neurological
Female
Psychological resilience
Alzheimer's Disease Neuroimaging Initiative
medicine.medical_specialty
Demographics
media_common.quotation_subject
Models
Neurological

and over
Article
03 medical and health sciences
Genetic
Alzheimer Disease
Clinical Research
Internal medicine
mental disorders
medicine
Acquired Cognitive Impairment
Dementia
Humans
Genetic Predisposition to Disease
Cognitive Dysfunction
Aged
Models
Genetic

Resilience
business.industry
Prevention
lcsh:R
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Alzheimer’s Disease Neuroimaging Initiative
medicine.disease
Brain Disorders
4.1 Discovery and preclinical testing of markers and technologies
030104 developmental biology
Psychological
lcsh:Q
Biochemistry and Cell Biology
biology.gene
business
030217 neurology & neurosurgery
Zdroj: Scientific reports, vol 9, iss 1
Scientific Reports
Medical Biophysics Publications
Varatharajah, Yogatheesan; Ramanan, Vijay K; Iyer, Ravishankar; Vemuri, Prashanthi; & Alzheimer’s Disease Neuroimaging Initiative,. (2019). Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.. Scientific reports, 9(1), 2235. doi: 10.1038/s41598-019-38793-3. UCSF: Retrieved from: http://www.escholarship.org/uc/item/63h3f0tp
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
DOI: 10.1038/s41598-019-38793-3.
Popis: In the Alzheimer’s disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) precedes AD dementia and identifying MCI individuals at risk of progression is important for clinical management. Our goal was to develop generalizable multivariate models that integrate high-dimensional data (multimodal neuroimaging and cerebrospinal fluid biomarkers, genetic factors, and measures of cognitive resilience) for identification of MCI individuals who progress to AD within 3 years. Our main findings were i) we were able to build generalizable models with clinically relevant accuracy (~93%) for identifying MCI individuals who progress to AD within 3 years; ii) markers of AD pathophysiology (amyloid, tau, neuronal injury) accounted for large shares of the variance in predicting progression; iii) our methodology allowed us to discover that expression of CR1 (complement receptor 1), an AD susceptibility gene involved in immune pathways, uniquely added independent predictive value. This work highlights the value of optimized machine learning approaches for analyzing multimodal patient information for making predictive assessments.
Databáze: OpenAIRE